Valicenti Advisory Services’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $569K | Sell |
3,916
-216
| -5% | -$29.8K | 0.11% | 66 |
|
|
2026
Q2 | $531K | Hold |
4,132
| – | – | 0.1% | 68 |
|
|
2026
Q1 | $497K | Sell |
4,132
-140
| -3% | -$16.2K | 0.11% | 69 |
|
|
2025
Q4 | $450K | Sell |
4,272
-15
| -0.3% | -$1.41K | 0.09% | 68 |
|
|
2025
Q3 | $360K | Buy |
+4,287
| New | +$353K | 0.08% | 73 |
|
|
2024
Q3 | – | Sell |
-1,657
| Closed | -$205K | – | 74 |
|
|
2024
Q2 | $205K | Sell |
1,657
-20
| -1% | -$2.58K | 0.06% | 75 |
|
|
2024
Q1 | $221K | Sell |
1,677
-298
| -15% | -$36.7K | 0.06% | 80 |
|
|
2023
Q4 | $215K | Sell |
1,975
-20
| -1% | -$2.08K | 0.07% | 78 |
|
|
2023
Q3 | $205K | Sell |
1,995
-50
| -2% | -$5.39K | 0.07% | 74 |
|
|
2023
Q2 | $236K | Sell |
2,045
-25
| -1% | -$2.84K | 0.07% | 76 |
|
|
2023
Q1 | $220K | Sell |
2,070
-236
| -10% | -$25.5K | 0.07% | 76 |
|
|
2022
Q4 | $256K | Sell |
2,306
-150
| -6% | -$15.3K | 0.09% | 69 |
|
|
2022
Q3 | $212K | Hold |
2,456
| – | – | 0.08% | 75 |
|
|
2022
Q2 | $224K | Sell |
2,456
-150
| -6% | -$13.3K | 0.07% | 78 |
|
|
2022
Q1 | $214K | Buy |
+2,606
| New | +$205K | 0.06% | 81 |
|
|
2021
Q4 | – | Sell |
-2,706
| Closed | -$203K | – | 86 |
|
|
2021
Q3 | $203K | Sell |
2,706
-100
| -4% | -$7.6K | 0.06% | 78 |
|
|
2021
Q2 | $218K | Sell |
2,806
-248
| -8% | -$18.4K | 0.06% | 78 |
|
|
2021
Q1 | $225K | Sell |
3,054
-105
| -3% | -$7.74K | 0.07% | 74 |
|
|
2020
Q4 | $247K | Buy |
3,159
+114
| +4% | +$8.72K | 0.08% | 68 |
|
|
2020
Q3 | $241K | Hold |
3,045
| – | – | 0.09% | 64 |
|
|
2020
Q2 | $225K | Hold |
3,045
| – | – | 0.09% | 61 |
|
|
2020
Q1 | $224K | Sell |
3,045
-179
| -6% | -$14.1K | 0.11% | 60 |
|
|
2019
Q4 | $280K | Sell |
3,224
-103
| -3% | -$8.46K | 0.12% | 65 |
|
|
2019
Q3 | $267K | Hold |
3,327
| – | – | 0.13% | 60 |
|
|
2019
Q2 | $266K | Sell |
3,327
-314
| -9% | -$24K | 0.13% | 60 |
|
|
2019
Q1 | $289K | Buy |
3,641
+1
| +0% | +$75 | 0.14% | 57 |
|
|
2018
Q4 | $265K | Buy |
3,640
+1
| +0% | +$71 | 0.13% | 59 |
|
|
2018
Q3 | $246K | Sell |
3,639
-114
| -3% | -$7.26K | 0.11% | 61 |
|
|
2018
Q2 | $217K | Sell |
3,753
-167
| -4% | -$9.42K | 0.1% | 61 |
|
|
2018
Q1 | $204K | Buy |
3,920
+2
| +0.1% | +$108 | 0.1% | 62 |
|
|
2017
Q4 | $210K | Hold |
3,918
| – | – | 0.1% | 59 |
|
|
2017
Q3 | $239K | Sell |
3,918
-41
| -1% | -$2.49K | 0.12% | 56 |
|
|
2017
Q2 | $242K | Buy |
3,959
+1
| +0% | +$61 | 0.13% | 56 |
|
|
2017
Q1 | $240K | Buy |
3,958
+1
| +0% | +$61 | 0.13% | 53 |
|
|
2016
Q4 | $222K | Buy |
3,957
+255
| +7% | +$14.9K | 0.14% | 50 |
|
|
2016
Q3 | $220K | Buy |
3,702
+2
| +0.1% | +$117 | 0.14% | 50 |
|
|
2016
Q2 | $203K | Buy |
+3,700
| New | +$197K | 0.13% | 48 |
|
|
2015
Q3 | – | Sell |
-3,697
| Closed | -$201K | – | 57 |
|
|
2015
Q2 | $201K | Sell |
3,697
-104
| -3% | -$5.83K | 0.13% | 57 |
|
|
2015
Q1 | $208K | Buy |
3,801
+1
| +0% | +$57 | 0.13% | 56 |
|
|
2014
Q4 | $206K | Buy |
3,800
+116
| +3% | +$6.46K | 0.12% | 54 |
|
|
2014
Q3 | $208K | Hold |
3,684
| – | – | 0.13% | 52 |
|
|
2014
Q2 | $203K | Sell |
3,684
-77
| -2% | -$4.2K | 0.13% | 49 |
|
|
2014
Q1 | $204K | Buy |
+3,761
| New | +$195K | 0.13% | 53 |
|
Other funds holding MRK
Valicenti Advisory Services's MRK Position: Q3 2026 in Review
Valicenti Advisory Services reduced its Merck (MRK) stake by 5.2% in Q3 2026, selling an estimated $29.8K and leaving 3,916 shares worth $569K. The position accounts for 0.11% of the portfolio, ranked #66.
Valicenti Advisory Services first reported a position in MRK in Q1 2014 and has held it in 43 quarters since. 1,933 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Valicenti Advisory Services held 3,916 shares of Merck worth $569K as of Q3 2026.
- Valicenti Advisory Services sold 216 Merck shares in Q3 2026, an estimated $29.8K.
- Merck made up 0.11% of Valicenti Advisory Services's portfolio in Q3 2026, its #66 holding.
- Valicenti Advisory Services first reported a position in Merck in Q1 2014 and has held it in 43 quarters since.
- 1,933 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Valicenti Advisory Services's 13F filing for Q3 2026, filed 23 Oct 2026.